end
closing procedures could result in an adjustment to the Company's third
quarter revenue numbers, and other risk factors detailed in CryoLife's
Securities and Exchange Commission filings, including CryoLife's Form 10-K
filing for the year ended December 31, 2006, its most recent Form 10-Q, and
the Company's other SEC filings. The Company does not undertake to update
its forward- looking statements.
Contacts:
D. Ashley Lee
Executive Vice President, Chief Operating Officer and
Chief Financial Officer
Phone: 770-419-3355
Katie Brazel
Fleishman Hillard
Phone: 404-739-0150
CRYOLIFE, INC.
Financial Highlights
(In thousands)
Three Months Ended Nine Months Ended
September 30, September 30,
2007 2006 2007 2006
(Unaudited) (Unaudited)
Revenues from:
Cardiovascular $ 5,566 $ 4,189 $ 15,587 $ 11,550
Vascular 5,215 4,468 16,782 13,066
Orthopaedic 566 1,662 3,650 5,223
Total preservation
services 11,347 10,319 36,019 29,839
BioGlue 10,280 9,444 32,373 29,534
Bioprosthetic device 157 243 480 774
CardioWrap 108 -- 243 --
Total products 10,545 9,687 33,096 30,308
Total product and
preservation services
revenues $ 21,892 $ 20,006 $ 69,115 $ 60,147
For additional information about the company, visit CryoLife'
'/>"/>
SOURCE CryoLife, Inc. Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related biology technology :1.
Speaker announces business members of IT Task Force2.
Doyle announces technology tax credits for Berbee3.
Doyle announces new energy, global warming policies4.
Doyle announces $80M renewable energy strategy5.
GE announces first installation of Discovery VCT6.
UWM announces winners of RGI awards7.
Third Wave announces two senior management appointments8.
Mirus announces new method for making antibodies9.
Merge announces sofware updates, upcoming acquisition10.
Small Tree announces ethernet solution for Apple Xserv G511.
TEKLYNX International announces new RFID software